A detailed history of Sit Investment Associates Inc transactions in Abbott Laboratories stock. As of the latest transaction made, Sit Investment Associates Inc holds 178,034 shares of ABT stock, worth $23 Million. This represents 0.45% of its overall portfolio holdings.

Number of Shares
178,034
Previous 196,454 9.38%
Holding current value
$23 Million
Previous $20.4 Million 0.57%
% of portfolio
0.45%
Previous 0.47%

Shares

30 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 13, 2024

SELL
$100.07 - $118.13 $1.84 Million - $2.18 Million
-18,420 Reduced 9.38%
178,034 $20.3 Million
Q2 2024

Aug 14, 2024

BUY
$100.73 - $112.44 $1.18 Million - $1.32 Million
11,710 Added 6.34%
196,454 $20.4 Million
Q1 2024

May 14, 2024

SELL
$109.52 - $120.96 $1.75 Million - $1.94 Million
-16,000 Reduced 7.97%
184,744 $21 Million
Q4 2023

Feb 13, 2024

SELL
$90.19 - $110.4 $874,843 - $1.07 Million
-9,700 Reduced 4.61%
200,744 $22.1 Million
Q3 2023

Nov 13, 2023

SELL
$95.53 - $114.62 $548,915 - $658,606
-5,746 Reduced 2.66%
210,444 $20.4 Million
Q2 2023

Aug 10, 2023

BUY
$100.78 - $112.29 $197,024 - $219,526
1,955 Added 0.91%
216,190 $23.6 Million
Q1 2023

May 11, 2023

BUY
$96.86 - $114.01 $1.79 Million - $2.1 Million
18,434 Added 9.41%
214,235 $21.7 Million
Q4 2022

Feb 10, 2023

BUY
$95.06 - $111.52 $230,235 - $270,101
2,422 Added 1.25%
195,801 $21.5 Million
Q3 2022

Nov 10, 2022

SELL
$96.76 - $112.03 $487,670 - $564,631
-5,040 Reduced 2.54%
193,379 $18.7 Million
Q2 2022

Aug 11, 2022

BUY
$102.07 - $123.37 $5.09 Million - $6.15 Million
49,870 Added 33.57%
198,419 $21.6 Million
Q1 2022

May 12, 2022

BUY
$114.02 - $139.04 $585,948 - $714,526
5,139 Added 3.58%
148,549 $17.6 Million
Q4 2021

Feb 11, 2022

SELL
$115.53 - $141.46 $5.78 Million - $7.08 Million
-50,060 Reduced 25.87%
143,410 $20.2 Million
Q3 2021

Nov 12, 2021

SELL
$116.66 - $129.06 $1.58 Million - $1.74 Million
-13,515 Reduced 6.53%
193,470 $22.9 Million
Q2 2021

Aug 13, 2021

SELL
$105.79 - $124.53 $914,448 - $1.08 Million
-8,644 Reduced 4.01%
206,985 $24 Million
Q1 2021

May 13, 2021

BUY
$108.84 - $128.23 $741,962 - $874,143
6,817 Added 3.26%
215,629 $25.8 Million
Q4 2020

Feb 11, 2021

SELL
$105.0 - $114.42 $1.07 Million - $1.17 Million
-10,198 Reduced 4.66%
208,812 $22.9 Million
Q3 2020

Nov 12, 2020

BUY
$91.64 - $111.29 $347,315 - $421,789
3,790 Added 1.76%
219,010 $23.8 Million
Q3 2020

Nov 12, 2020

SELL
$91.64 - $111.29 $1.36 Million - $1.65 Million
-14,825 Reduced 6.44%
215,220 $18 Million
Q2 2020

Aug 13, 2020

SELL
$76.57 - $98.0 $2.94 Million - $3.76 Million
-38,355 Reduced 14.29%
230,045 $21 Million
Q1 2020

May 13, 2020

SELL
$62.82 - $91.86 $181,549 - $265,475
-2,890 Reduced 1.07%
268,400 $21.2 Million
Q4 2019

Feb 13, 2020

BUY
$78.51 - $87.4 $4.4 Million - $4.9 Million
56,070 Added 26.05%
271,290 $23.6 Million
Q3 2019

Nov 13, 2019

SELL
$81.84 - $88.74 $356,004 - $386,019
-4,350 Reduced 1.98%
215,220 $18 Million
Q2 2019

Aug 14, 2019

SELL
$72.88 - $85.0 $3.73 Million - $4.35 Million
-51,225 Reduced 18.92%
219,570 $18.5 Million
Q1 2019

May 14, 2019

SELL
$66.22 - $80.06 $6.68 Million - $8.08 Million
-100,940 Reduced 27.15%
270,795 $21.6 Million
Q4 2018

Jan 14, 2019

SELL
$65.56 - $74.27 $13.4 Million - $15.2 Million
-204,350 Reduced 35.47%
371,735 $26.9 Million
Q3 2018

Nov 14, 2018

SELL
$60.81 - $73.36 $3.44 Million - $4.16 Million
-56,650 Reduced 8.95%
576,085 $42.3 Million
Q2 2018

Jul 19, 2018

BUY
$57.57 - $63.54 $87,218 - $96,263
1,515 Added 0.24%
632,735 $38.6 Million
Q1 2018

Apr 20, 2018

BUY
$56.27 - $63.62 $689,307 - $779,345
12,250 Added 1.98%
631,220 $37.8 Million
Q4 2017

Jan 10, 2018

SELL
$53.68 - $57.47 $5.83 Million - $6.24 Million
-108,550 Reduced 14.92%
618,970 $35.3 Million
Q3 2017

Oct 18, 2017

BUY
$48.06 - $53.64 $35 Million - $39 Million
727,520
727,520 $38.8 Million

Others Institutions Holding ABT

About ABBOTT LABORATORIES


  • Ticker ABT
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 1,751,219,968
  • Market Cap $227B
  • Description
  • Abbott Laboratories, together with its subsidiaries, discovers, develops, manufactures, and sells health care products worldwide. It operates in four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The Established Pharmaceutical Products segment provides generic pharmaceuticals for t...
More about ABT
Track This Portfolio

Track Sit Investment Associates Inc Portfolio

Follow Sit Investment Associates Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Sit Investment Associates Inc, based on Form 13F filings with the SEC.

News

Stay updated on Sit Investment Associates Inc with notifications on news.